Dec 2016 - Perspective - Doc # US42042415
Perspective: Changing Times in Commercial Life Science IT — How a Trump Administration Will Affect Current and Future Initiatives
This IDC Health Insights Perspective examines the impact of a Trump administration on commercial life science IT. Donald Trump campaigned on his intention to "repeal and replace" the Patient Protection and Affordable Care Act, commonly referred to as the ACA or "Obamacare," along with several other proposals, which will have a major impact on life science companies and the IT vendors that serve them. Republican majorities in the U.S. House of Representatives and Senate may be poised to turn his campaign promises into legislation with far-reaching effects on the nation's healthcare system.